Acumen Pharmaceuticals
ABOS
#10834
Rank
S$17.4 M
Marketcap
S$0.24
Share price
-3.52%
Change (1 day)
-88.27%
Change (1 year)

Earnings for Acumen Pharmaceuticals (ABOS)

Earnings in 2026 (TTM): -S$0.13 Billion

According to Acumen Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acumen Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.13 Billion-15.14%
2025 -S$0.16 Billion19.18%
2024 -S$0.13 Billion118.3%
2023 -S$58.07 Million-0.5%
2022 -S$58.36 Million-173.58%
2021 S$79.31 M-876.96%
2020 -S$10.21 Million